Panel session 15:30
Watch the programGrand Hall
A unifying role of the GxP in the conditions of the changing reality. Part 1
Questions and topics for discussion
• Drug safety for the nation Drug quality assurance in the light of new legislative measures and initiatives
• Good distribution practice New logistics chains, supply chains and sales channels
• Compliance with the good pharmacy practice: what is the future of the target market?
• Good pharmacovigilance practice
The Session Partner: PRO.MED.CS Praha a.s.
Moderator
Lilia Titova
Executive Director of the Union of Professional Pharmaceutical Organisations
Participants
Tatiana Sitko
Adviser of the Pharmaceutical Inspection Department, Head Office for Quality Control of Medical Care, Medical Expertise, Appeals of Citizens and Legal Entities, Ministry of Health of Belarus
Viktoria Presnyakova
Chairperson of the board of the Independent Pharmacies Association
Maria Ponomaryova
Adviser of the Pharmaceutical Inspection Department, Head Office for Quality Control of Medical Care, Medical Expertise, Appeals of Citizens and Legal Entities, Ministry of Health of Belarus
Judith Tibisay Delgado
Executive Secretary of the Review Board of Pharmaceutical Products, National Institute of Hygiene “Rafael Rangel”, Venezuela
Fleurdelis E. Mendiola
Pharmacist IV, Food and Drug Administration, Philippines
Filiz Ozul
Head of Medicines Inspection Department, Turkish Medicines and Medical Devices Agency, Turkey
Anatoly Krasheninnikov
Director General, National Pharmacovigilance Research Centre
Ashraf Hossain
Director, Directorate General of Drug Administration (DGDA), Bangladesh
Dmitry Voloshin
Founder of the proGMP.ru web portal
Olga Lidia Jacobo Casanueva
Director, Center for the State Control of Medicines, Equipment and Medical Devices (CECMED)
